Stock FAQs

mjn stock price

by Madaline Stokes Published 3 years ago Updated 2 years ago
image

89.98

What is Mead Johnson Nutrition's (MJN) stock price?

Mead Johnson Nutrition trades on the New York Stock Exchange (NYSE) under the ticker symbol "MJN." What is Mead Johnson Nutrition's stock price today? One share of MJN stock can currently be purchased for approximately $89.98. What is Mead Johnson Nutrition's official website? The official website for Mead Johnson Nutrition is www.meadjohnson.com.

How do I buy shares of MJN?

Shares of MJN and other Canadian stocks can be purchased through an online brokerage account.

What does MJ Holdings Inc do?

MJ Holdings Inc. MJ Holdings, Inc. operates as a cannabis holding company which provides services to the regulated cannabis industry. It offers cultivation management, licensing support, production management, asset and infrastructure development services.

image

Is Mead Johnson public?

Since then, Mead Johnson has been the best performing IPO stock on the New York Stock Exchange, with an increase of nearly 80% from its initial offering share price. The company's total market capitalization stands at more than $8.8 billion, and its stock is one of the newest additions to the S&P 500 Index.

Is Enfamil a publicly traded company?

Mead Johnson & Company, LLC is an American company that operates as an independent subsidiary of Reckitt. It is a leading manufacturer of infant formula both domestically and globally with its flagship product Enfamil....Mead Johnson.TypeSubsidiary (LLC)Websitewww.meadjohnson.com8 more rows

What is Enfamil Stock Symbol?

MJNMead Johnson Nutrition Company (NYSE:MJN) , the Enfamil infant formula-maker is fast moving toward concluding the agreement of acquisition with renowned British consumer-products...

What is the stock symbol for baby formula?

(BABYF) Stock Price, News, Quote & History - Yahoo Finance.

Does Similac have a stock?

To find major retailers online and near you that stock Similac products, select the category and type of formula you're looking for, then enter your location. Because inventory is rapidly changing and availability may vary by store, we recommend calling ahead to make sure your product is still in stock.

Is Enfamil owned by Nestle?

Infant nutrition is a key battleground for Nestle and its rivals Danone DANO.PA and Reckitt Benckiser RB. L, which bought Enfamil infant formula maker Mead Johnson.

Who owns Enfamil stock?

About Mead Johnson Mead Johnson develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide primarily under the "Enfa" family of brands, including Enfamil® infant formula.

What company owns Enfamil?

Enfamil (a play on words of 'infant meal') is an American brand of infant formula that is made by Mead Johnson, a subsidiary of Reckitt.

Why is enfagrow out of stock?

Due to limited retail distribution and customer demand, our Enfagrow Soy Toddler Transitions powder will be discontinued effective June 30, 2019. We will continue to produce Enfagrow Toddler Transitions and Enfagrow Toddler Transitions Gentlease products.

Is Babyf a good stock to buy?

1 equities research analysts have issued 1-year price targets for Else Nutrition's shares. Their BABYF stock forecasts range from $2.00 to $2.00. On average, they predict Else Nutrition's share price to reach $2.00 in the next year. This suggests a possible upside of 318.9% from the stock's current price.

What formulas are in stock?

Important Formulas of Stocks and SharesStock purchased/sold = Investment × 100/Market Price.Investment/Cash required = Stock × Market Price/100.Income/Dividend = Stock × Rate/100.Stock purchased/sold = Income × 100/Rate%Investment/Cash required = Income ×Market Price/Rate%More items...

Is ABT a buy?

Out of 11 analysts, 5 (45.45%) are recommending ABT as a Strong Buy, 3 (27.27%) are recommending ABT as a Buy, 2 (18.18%) are recommending ABT as a Hold, 1 (9.09%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell. What is ABT's earnings growth forecast for 2022-2024?

Does Mead Johnson own Enfamil?

Glenview-based Mead Johnson, maker of baby formula, sold to British firm for $16.6 billion. Enfamil baby formula is made by Chicago-based Mead Johnson. The company, which moved its headquarters from Glenview to Chicago in March, is being acquired by British firm Reckitt Benckiser.

Who makes Enfamil and Similac?

Abbott LaboratoriesAbbott Laboratories, which makes Similac, and Mead Johnson, which makes Enfamil, each control about 40 percent of the market.

Who manufactures Enfamil and Similac?

AbbottAbbott says it will resume producing Similac baby formula within two weeks at its Michigan plant. Since February, the outage for the leading brand has led to severe shortages across the US. Now, Abbott and its competitors are taking dramatic measures to get supplies on to store shelves.

Who makes the baby formula Enfamil?

Enfamil maker Reckitt cranks up operations to put baby formula on U.S shelves.

How were Mead Johnson Nutrition's earnings last quarter?

Mead Johnson Nutrition CO (NYSE:MJN) issued its quarterly earnings results on Thursday, April, 27th. The company reported $0.80 earnings per share...

Is Mead Johnson Nutrition a good dividend stock?

Mead Johnson Nutrition(NYSE:MJN) pays an annual dividend of $1.65 per share and currently has a dividend yield of 0.00%. View Mead Johnson Nutriti...

Who are Mead Johnson Nutrition's key executives?

Mead Johnson Nutrition's management team includes the following people: Peter Kasper Jakobsen , President, Chief Executive Officer, Director Mich...

Who are some of Mead Johnson Nutrition's key competitors?

Some companies that are related to Mead Johnson Nutrition include Hershey (HSY) , Mondelez International (MDLZ) , General Mills (GIS) , Tyson F...

What other stocks do shareholders of Mead Johnson Nutrition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mead Johnson Nutrition investors own include Ford Motor (F...

What is Mead Johnson Nutrition's stock symbol?

Mead Johnson Nutrition trades on the New York Stock Exchange (NYSE) under the ticker symbol "MJN."

What is Mead Johnson Nutrition's stock price today?

One share of MJN stock can currently be purchased for approximately $89.98.

What is Mead Johnson Nutrition's official website?

The official website for Mead Johnson Nutrition is www.meadjohnson.com .

How can I contact Mead Johnson Nutrition?

Mead Johnson Nutrition's mailing address is 225 N Canal St Fl 25, CHICAGO, IL 60606-1791, United States . The company can be reached via phone at...

How has Cronos Group's stock performed in 2022?

Cronos Group's stock was trading at C$12.15 at the beginning of 2022. Since then, MJN shares have increased by 0.0% and is now trading at C$12.15....

Is Cronos Group a good dividend stock?

Cronos Group(CVE:MJN) pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people: Michael Ryan Gorenstein , President, Chief Executive Officer, Vice Chairman of the...

Who are some of Cronos Group's key competitors?

Some companies that are related to Cronos Group include Innovative Industrial Properties (IIPR) , Canopy Growth (WEED) , MassRoots (MSRT) , Can...

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC) , Cronos Group...

What is Cronos Group's stock symbol?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

How do I buy shares of Cronos Group?

Shares of MJN and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian...

What is Cronos Group's stock price today?

One share of MJN stock can currently be purchased for approximately C$12.15.

How much money does Cronos Group make?

Cronos Group (CVE:MJN) has a market capitalization of C$1.73 billion.

Is Cronos Group a good dividend stock?

Who are some of Cronos Group's key competitors?

Cronos Group pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Cronos Group own?

Some companies that are related to Cronos Group include Innovative Industrial Properties (IIPR), Canopy Growth (WEED), CanniMed Therapeutics (CMED), OrganiGram (OGI), GrowGeneration (GRWG), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Bioventix (BVXP), Maple Leaf Green World (MGW), KushCo (KSHB), Net Savings Link (NSAV), Unrivaled Brands (TRTC) and General Cannabis (CANN). View all of MJN's competitors..

What is Cronos Group's stock symbol?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), OrganiGram (OGI), Aphria (APHA), IMV (IMV), Leaf Mobile (LEAF), Aurora Cannabis (ACB) and CanniMed Therapeutics (CMED).

How do I buy shares of Cronos Group?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

What is Cronos Group's stock price today?

Shares of MJN and other Canadian stocks can be purchased through an online brokerage account.

Where are Cronos Group's headquarters?

One share of MJN stock can currently be purchased for approximately C$12.15.

Component Grades

Cronos Group is headquartered at 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada.

Mead Johnson Nutrition Company (MJN) Company Bio

We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9